Fig. 8 | Signal Transduction and Targeted Therapy

Fig. 8

From: Clinical investigation on nebulized human umbilical cord MSC-derived extracellular vesicles for pulmonary fibrosis treatment

Fig. 8

Clinical safety of nebulized hUCMSC-EVs on patients with pulmonary fibrosis. a A flow diagram for a phase I clinical trial. The image was created using MedPeer. Laboratory examinations of WBC (b), Neutrophils (c), LYM (d), RBC (e), Hb (f), PLT (g), ALT (h), AST (i), BUN (j), Cr (k), IL-6 (l) before and after the treatment with nebulized saline and hUCMSC-EVs in the clinical trial were performed. WBC White Blood Cell. LYM Lymphocyte. RBC: red blood cell. Hb Hemoglobin. PLT Platelet. ALT Alanine Aminotransferase. AST Aspartate Aminotransferase. BUN Blood Urea Nitrogen. Cr Creatinine. IL-6 Interleukin-6

Back to article page